The Venture Codex Logo

The Venture Codex

NATCO Pharmaceuticals

Natco House, Road No.2, Banjara Hills, Hyderabad, Telangana, 500034, India

Overview

Manufacturer of affordable medicines meeting global standards.

Founded

1995

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B
Series D

Geographic focus

India
United States

Sector focus

Health Care
Manufacturing
Medical

Investment portfolio

3rounds
NAMEDATESIZE
Eyestem
Oct 2025Participated
$2 MSeries B
EGenesis
Sep 2024Participated
$191 MSeries D
Cellogen Therapeutics
Jan 2024Led
$2 MOther Equity
Eyestem
Oct 2025Participated
$2 MSeries B
EGenesis
Sep 2024Participated
$191 MSeries D
Cellogen Therapeutics
Jan 2024Led
$2 MOther Equity
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

NATCO Pharmaceuticals: 3 funding rounds are recorded in the selected participation categories.All available history.
NATCO Pharmaceuticals: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B01
Series C+01
Other Equity10

Monthly Deal Activity

NATCO Pharmaceuticals: 3 deals are recorded across 34 months.All available history.
NATCO Pharmaceuticals: 3 deals are recorded across 34 months. All available history
MonthDeals
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

NATCO Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

NATCO Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3

Deal Size Distribution

NATCO Pharmaceuticals: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

NATCO Pharmaceuticals: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

NATCO Pharmaceuticals: India has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

NATCO Pharmaceuticals: India has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
India2
United States1
NATCO Pharmaceuticals: 16 co-investors are shown, with Alkem sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

NATCO Pharmaceuticals: 16 co-investors are shown, with Alkem sharing 1 recorded deals. All available history
Co-investorShared deals
Alkem1
Alta Partners1
ARCH Venture Partners1
Barmenia Next Strategies1
DaVita1
Eisai Innovation1
Farallon Capital Management1
Fastspeed Vanijya1
Fresenius Medical Care Ventures1
Jacesa Investments1
Khosla Ventures1
Leaps by Bayer1
Lux Capital1
Parkwood1
Prabhavati Agro Green Energies1
Satprem Trust1

Investment Strategy

NATCO Pharmaceuticals: Led accounts for 33% and participating for 67% of round participation.All available history.
NATCO Pharmaceuticals: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
NATCO Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
NATCO Pharmaceuticals: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Appa Rao S V V N

Chief Financial Officer

Rajeev Nannapaneni

Vice Chairman and CEO

V.C. Nannapaneni

Founder and Chairman